Article · 17 Jun 2026
Conference abstractPublished 23 Sep 2024
Method Development and Validation for Simultaneous Estimation of Aspirin and
India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The aim of this study was to develop and validate a reliable and efficient RP-HPLC method for the simultaneous estimation of Aspirin and Dipyridamol in capsule dosage forms.The objective was to establish a simple, rapid, and accurate chromatographic method to quantify Aspirin and Dipyridamol simultaneously in pharmaceutical formulations, ensuring its suitability for routine quality control analysis.The method was developed using a Shimadzu HPLC system equipped with a C18 column (250 mm × 4.6 mm, 5 μm). The mobile phase consisted of a mixture of phosphate buffer (pH 3.0) and methanol in a 60:40 (v/v) ratio, with a flow rate of 1.2 mL/min. Detection was carried out at 254 nm. The retention times for Aspirin and Dipyridamol were found to be 4.2 and 6.5 minutes, respectively. The method was validated for linearity, accuracy, precision, specificity, robustness and system suitability in accordance with ICH guidelines.The method demonstrated linearity in the concentration ranges of 10–100 μg/mL for Aspirin and 5–50 μg/mL for Dipyridamol, with correlation coefficients (R²) exceeding 0.999 for both compounds. The accuracy of the method was confirmed with recovery values ranging from 98% to 102%. Precision was validated with RSD values of less than 2% for intra-day and inter-day variations. The method was found to be specific with no interference from excipients in the capsule formulations and robustness testing showed reliable performance under slight variations in chromatographic conditions.The developed RP-HPLC method provides an efficient, accurate, and precise approach for the simultaneous estimation of Aspirin and Dipyridamol in capsules. This validated method is suitable for routine quality control and can be used for the analysis of these drugs in pharmaceutical formulations .
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 3 May 2019
Development and Validation of First Order Derivative Spectrophotometric Method for Simultaneous Estimation of Atorvastatin Calcium and Aspirin in Capsules
Research article · 3 May 2019
Development and Validation of First Order Derivative Spectrophotometric Method for Simultaneous Estimation of Rosuvastatin Calcium and Aspirin in Capsule Dosage Form
Article · 10 Mar 2016
Development and Validation of Stability Indicating RP-HPLC Method for Simultaneous Estimation of Ramipril, Aspirin and Simvastatin in Bulk and Pharmaceutical Dosage Form
Research article · 30 Oct 2020
Development and Validation of HPTLC Method for Simultaneous Quantification of Aspirin and Omeprazole in Bulk and Marketed Formulation
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “G.Amani”

